Pancreatic Cancer Research

ResearcherUniversity Health NetworkNo recent work listed

Natalie Cook

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2606-1082; OpenAlex author ID A5070242435. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2011: 2 papers · 2012: 5 papers · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers

Papers 14

  1. A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2017.495↗
  2. Exome-Wide Association Study of Pancreatic Cancer Risk. Co-author DOI 10.1053/j.gastro.2017.10.015↗
  3. FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience. First author DOI 10.1038/bjc.2016.222↗
  4. Endothelin-1 and endothelin B receptor expression in pancreatic adenocarcinoma. Co-author DOI 10.1136/jclinpath-2014-202521↗
  5. Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo. Co-author DOI 10.1038/bjc.2014.288↗
  6. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2012-302529↗
  7. Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0067330↗
  8. A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer. Co-author DOI 10.1002/sim.5331↗
  9. Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials. Co-author DOI 10.1016/j.pan.2011.12.009↗
  10. Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. Co-author DOI 10.1084/jem.20111923↗
  11. Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. Co-author DOI 10.1136/gutjnl-2011-300850↗
  12. nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. Co-author DOI 10.1158/2159-8290.cd-11-0242↗
  13. Stromal biology and therapy in pancreatic cancer. Co-author DOI 10.1136/gut.2010.226092↗
  14. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. Co-author DOI 10.1172/jci45797↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Arthur Tuveson · 10 shared papers, 2011–2018 · strength 0.34
  2. Duncan Ian Jodrell · 8 shared papers, 2012–2018 · strength 0.29
  3. Albrecht Neeße · 6 shared papers, 2011–2014 · strength 0.19
  4. Kristopher K. Frese · 6 shared papers, 2011–2014 · strength 0.19
  5. Tashinga E. Bapiro · 5 shared papers, 2012–2014 · strength 0.17
  6. Aarthi Gopinathan · 3 shared papers, 2012–2018 · strength 0.12
  7. Malcolm J. Moore · 2 shared papers, 2016–2018 · strength 0.12
  8. Rebecca J. Brais · 2 shared papers, 2012–2015 · strength 0.09
  9. Pippa G. Corrie · 2 shared papers, 2012–2015 · strength 0.09
  10. Aurélie Courtin · 2 shared papers, 2013–2014 · strength 0.08
  11. Frances M. Richards · 2 shared papers, 2013–2014 · strength 0.08
  12. William P. Steward · 1 shared paper, 2018 · strength 0.06
  13. Alan Anthoney · 1 shared paper, 2018 · strength 0.06
  14. David J. Propper · 1 shared paper, 2018 · strength 0.06
  15. Sean Patrick Cleary · 1 shared paper, 2018 · strength 0.06
  16. Daniel H. Palmer · 1 shared paper, 2018 · strength 0.06
  17. Ashton Anthony Connor · 1 shared paper, 2018 · strength 0.06
  18. Ayelet Borgida · 1 shared paper, 2018 · strength 0.06
  19. Sean Michael Grimmond · 1 shared paper, 2018 · strength 0.06
  20. Robert C. Grant · 1 shared paper, 2018 · strength 0.06
  21. Alyssa L. Smith · 1 shared paper, 2018 · strength 0.06
  22. Alison P. Klein · 1 shared paper, 2018 · strength 0.06
  23. Nicholas Jason Roberts · 1 shared paper, 2018 · strength 0.06
  24. Steve Gallinger · 1 shared paper, 2018 · strength 0.06
  25. Bristi Basu · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.